Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris Labaki

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
JAMA Network Open|November 12, 2021
Association Between Androgen Deprivation Therapy and Mortality Among Patients With Prostate Cancer and COVID-19Andrew L Schmidt, Matthew D Tucker, Ziad Bakouny, et al.
Cell Reports|June 13, 2024
Epigenomic signatures of sarcomatoid differentiation to guide the treatment of renal cell carcinomaTalal El Zarif, Karl Semaan, Marc Eid, et al.
BMC Cancer|March 23, 2023
Impact of COVID-19 in patients on active melanoma therapy and with history of melanomaDouglas B Johnson, Michael B Atkins, Cassandra Hennessy, et al.
Cancers|September 9, 2022
Demographics, Outcomes, and Risk Factors for Patients with Sarcoma and COVID-19: A CCC19-Registry Based Retrospective Cohort StudyMichael J Wagner, Cassandra Hennessy, Alicia Beeghly, et al.
Lancet Regional Health. Americas|February 23, 2023
Breakthrough SARS-CoV-2 infections among patients with cancer following two and three doses of COVID-19 mRNA vaccines: a retrospective observational study from the COVID-19 and Cancer ConsortiumToni K Choueiri, Chris Labaki, Ziad Bakouny, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2025
Tumor-Intrinsic and Microenvironmental Determinants of Impaired Antitumor Immunity in Chromophobe Renal Cell CarcinomaChris Labaki, Eddy Saad, Katrine N Madsen, et al.
The Lancet. Healthy Longevity|February 21, 2022
Geriatric risk factors for serious COVID-19 outcomes among older adults with cancer: a cohort study from the COVID-19 and Cancer ConsortiumArielle Elkrief, Cassandra Hennessy, Nicole M Kuderer, et al.
JAMA Network Open|January 4, 2022
Assessment of Regional Variability in COVID-19 Outcomes Among Patients With Cancer in the United StatesJessica E Hawley, Tianyi Sun, David D Chism, et al.
Open Forum Infectious Diseases|February 24, 2022
Coinfections in Patients With Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) StudyGowri Satyanarayana, Kyle T Enriquez, Tianyi Sun, et al.
JAMA Oncology|August 17, 2023
Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19Shuchi Gulati, Chih-Yuan Hsu, Surbhi Shah, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
JAMA Network Open|November 12, 2021
Association Between Androgen Deprivation Therapy and Mortality Among Patients With Prostate Cancer and COVID-19Andrew L Schmidt, Matthew D Tucker, Ziad Bakouny, et al.
Cell Reports|June 13, 2024
Epigenomic signatures of sarcomatoid differentiation to guide the treatment of renal cell carcinomaTalal El Zarif, Karl Semaan, Marc Eid, et al.
BMC Cancer|March 23, 2023
Impact of COVID-19 in patients on active melanoma therapy and with history of melanomaDouglas B Johnson, Michael B Atkins, Cassandra Hennessy, et al.
Cancers|September 9, 2022
Demographics, Outcomes, and Risk Factors for Patients with Sarcoma and COVID-19: A CCC19-Registry Based Retrospective Cohort StudyMichael J Wagner, Cassandra Hennessy, Alicia Beeghly, et al.
Lancet Regional Health. Americas|February 23, 2023
Breakthrough SARS-CoV-2 infections among patients with cancer following two and three doses of COVID-19 mRNA vaccines: a retrospective observational study from the COVID-19 and Cancer ConsortiumToni K Choueiri, Chris Labaki, Ziad Bakouny, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2025
Tumor-Intrinsic and Microenvironmental Determinants of Impaired Antitumor Immunity in Chromophobe Renal Cell CarcinomaChris Labaki, Eddy Saad, Katrine N Madsen, et al.
The Lancet. Healthy Longevity|February 21, 2022
Geriatric risk factors for serious COVID-19 outcomes among older adults with cancer: a cohort study from the COVID-19 and Cancer ConsortiumArielle Elkrief, Cassandra Hennessy, Nicole M Kuderer, et al.
JAMA Network Open|January 4, 2022
Assessment of Regional Variability in COVID-19 Outcomes Among Patients With Cancer in the United StatesJessica E Hawley, Tianyi Sun, David D Chism, et al.
Open Forum Infectious Diseases|February 24, 2022
Coinfections in Patients With Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) StudyGowri Satyanarayana, Kyle T Enriquez, Tianyi Sun, et al.
JAMA Oncology|August 17, 2023
Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19Shuchi Gulati, Chih-Yuan Hsu, Surbhi Shah, et al.
Pageof 8